Poziotinib Inhibits HER2-Mutant-Driven Therapeutic Resistance and Multiorgan Metastasis in Breast Cancer.
Kalra R, Chen CH, Wang J, Salam AB, Dobrolecki LE, Lewis A, Sallas C, Yates CC, Gutierrez C, Karanam B, Anurag M, Lim B, Ellis MJ, Kavuri SM.
Kalra R, et al.
Cancer Res. 2022 Aug 16;82(16):2928-2939. doi: 10.1158/0008-5472.CAN-21-3106.
Cancer Res. 2022.
PMID: 35736563
Free PMC article.